Log In
BCIQ
Print this Print this
 

CD101 topical (formerly Topifungin)

  Manage Alerts
Collapse Summary General Information
Company Cidara Therapeutics Inc.
DescriptionTopical formulation of biafungin, an echinocandin antifungal
Molecular Target
Mechanism of ActionAntifungal agent
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationCandida
Indication DetailsPrevent recurrent vulvovaginal candidiasis; Treat moderate to severe vulvovaginal candidiasis; Treat vulvovaginal candidiasis
Regulatory Designation U.S. - Fast Track (Treat vulvovaginal candidiasis);
U.S. - Fast Track (Prevent recurrent vulvovaginal candidiasis);
U.S. - Qualified Infectious Disease Program (Prevent recurrent vulvovaginal candidiasis);
U.S. - Qualified Infectious Disease Program (Treat vulvovaginal candidiasis)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today